Eli Lilly Forecasts 2024 Adjusted EPS Of $16.10-$16.60 Versus Prior Range Of $13.50-$14.00 And Consensus Of $13.74
Portfolio Pulse from Benzinga Newsdesk
Eli Lilly has updated its 2024 adjusted EPS forecast to a range of $16.10-$16.60, significantly higher than the previous range of $13.50-$14.00 and the consensus estimate of $13.74.
August 08, 2024 | 10:51 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Eli Lilly has significantly raised its 2024 adjusted EPS forecast to $16.10-$16.60, compared to the prior range of $13.50-$14.00 and the consensus estimate of $13.74. This positive revision is likely to boost investor confidence and drive the stock price higher in the short term.
The significant upward revision in the EPS forecast indicates strong financial performance and growth prospects for Eli Lilly. This is likely to attract investor interest and result in a positive short-term impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100